NEW YORK (Reuters Health) – While elevated levels of anticardiolipin antibodies are associated with preeclampsia, measuring levels of anticardiolipin antibodies cannot be used to predict risk of preeclampsia…
NEW YORK (Reuters Health) – Over time, cervical intraepithelial neoplasia (CIN) grade 2 eventually resolves spontaneously in about two-thirds of adolescent and young adult women, according to findings…
NEW YORK (Reuters Health) – Ultrasound-guided high-intensity focused ultrasound (HIFU) ablation and the levonorgestrel intrauterine system (LNG-IUS) offer less invasive options for treating women with symptomatic adenomyosis, according…
NEW YORK (Reuters Health) – Routine screening for coagulation abnormalities before oocyte retrieval for in vitro fertilization (IVF) is costly and not clinically effective, researchers from Israel found…
NEW YORK (Reuters Health) – Magnetic resonance imaging of ovarian tumors is useful in predicting whether the lesion is malignant or benign, thereby helping to guide the therapeutic…
NEW YORK (Reuters Health) – The likelihood that a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) will be upstaged to invasive breast cancer on final…
NEW YORK (Reuters Health) – A selective with antiprogestin effects, CDB-2914, reduces uterine fibroid size and bleeding, and improves quality of life in affected women, according to a…
NEW YORK (Reuters Health) – Almost a quarter of overweight women and nearly a half of overweight men in the US think there’s nothing wrong with their weight.…
NEW YORK (Reuters Health) – Compared with zoledronic acid, the monoclonal antibody denosumab is more effective in delaying skeletal-related events in women with breast cancer that has metastasized…
NEW YORK (Reuters Health) – Benign or malignant breast lesions can be differentiated noninvasively by overlaying 3-D digital mammography images with tissue-physiology images obtained by scanning with near…